XML 21 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net earnings (loss) $ (3.7) $ 301.3
Adjustments to reconcile net (loss) earnings to net cash provided by operating activities:    
Depreciation and amortization 1,471.6 1,501.0
Share-based Compensation 50.9 (8.6)
Deferred income tax benefit (158.0) (149.9)
Loss from equity method investments 43.6 58.6
Other non-cash items 124.2 238.3
Litigation settlements and other contingencies, net 13.5 (40.9)
Changes in operating assets and liabilities:    
Accounts receivable (20.7) 262.2
Inventories (477.6) (425.5)
Accounts payable (83.2) (14.1)
Income taxes (60.2) (97.4)
Other operating assets and liabilities, net 216.6 80.6
Net cash provided by operating activities 1,117.0 1,705.6
Cash flows from investing activities:    
Cash paid for acquisitions, net (148.7) (307.1)
Capital expenditures (139.6) (137.4)
Purchase of available for sale securities and other investments (19.5) (49.4)
Proceeds from the sale of marketable securities 19.1 72.1
Payments for product rights and other, net (146.5) (613.0)
Proceeds from the sale of assets 24.3 0.0
Net cash used in investing activities (410.9) (1,034.8)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 6.4 2,577.7
Payments of long-term debt (657.1) (2,598.6)
Purchase of ordinary shares 0.0 (432.0)
Change in short-term borrowings, net (1.9) (45.9)
Taxes paid related to net share settlement of equity awards (8.4) (10.1)
Contingent consideration payments (47.8) (0.2)
Payments of financing fees (2.7) (20.8)
Proceeds from exercise of stock options 8.0 15.6
Other items, net (1.1) (0.4)
Net cash used in financing activities (704.6) (514.7)
Effect on cash of changes in exchange rates (16.4) (22.9)
Net (decrease) increase in cash, cash equivalents and restricted cash (14.9) 133.2
Cash, cash equivalents and restricted cash — beginning of period 389.3 369.9
Cash, cash equivalents and restricted cash — end of period $ 374.4 $ 503.1